Location History:
- Zürich, CH (2004 - 2015)
- Olivone, CH (2015)
- Uitikon, CH (2013 - 2016)
- Bioggio, CH (2015 - 2017)
- Bellinzona, CH (2017)
- Zurich, CH (2007 - 2020)
Company Filing History:
8 out of 36 
4 out of 6 
4 out of 4 
Years Active: 2004-2020
Title: Innovator Alcide Barberis: Pioneering Phospholipid Drug Analogs
Introduction
Alcide Barberis, an inventive mind based in Bioggio, Switzerland, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of five patents, Barberis has focused on developing phospholipid drug analogs that hold promise in medical applications.
Latest Patents
Among his latest innovations are compositions of compounds characterized by specific structures, as described in his patents. These compositions include pharmaceutically acceptable salts, tautomers, or hydrates, where the structural elements X, R, and n are meticulously defined. Furthermore, Barberis has outlined methods for preparing and utilizing these compounds, positioning his work at the forefront of pharmaceutical research.
Career Highlights
Throughout his career, Barberis has played vital roles in various companies within the biotechnology sector. Notably, he has been associated with Telormedix SA and Urogen Pharma Ltd., where he contributed his expertise to advance innovative solutions in drug development.
Collaborations
In addition to his corporate endeavors, Barberis has collaborated with esteemed colleagues such as Roberto Maj and Franco Pattarino. These partnerships have likely fostered an environment of creative synergy, enhancing the scope and impact of their research.
Conclusion
Alcide Barberis exemplifies the spirit of innovation in the pharmaceutical industry. His ongoing work on phospholipid drug analogs showcases his commitment to enhancing therapeutic options, ultimately benefiting practitioners and patients alike. As his research continues to evolve, it will be exciting to witness the future advancements stemming from his inventive contributions.